A Phase II Study of AT7519M, a CDK Inhibitor, in Patients with Chronic Lymphocytic Leukemia: NCIC CTG Trial IND.193 Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Seftel, Matthew D
  • Kuruvilla, John
  • Banerji, Versha
  • Fraser, Graeme
  • Xu, Hao
  • Powers, Jean
  • Crocker, Susan
  • Toguchi, Marcia
  • Lyons, John F
  • Seymour, Lesley
  • Hay, Annette E

publication date

  • December 6, 2014

published in